TABLE 4

Binding affinities (Ki; micromolar) for selected compounds at α adrenergic receptors

Values for α1A-, α1B-, and α2B-receptors determined by NovaScreen Biosciences, using their standard protocols as described for Table 3. Values for α2A and α2B receptors were conducted at Alcon and are the mean of at least three experiments ± S.E.M. where appropriate.


Compound

α1Aa

α1Bb

α2Ac [IC50]

α2Bd

α2Cc [IC50]
5-MeODMT >10 >10 13.5 ± 1.40 ∼1 6.93 ± 3.63
5-HOAMT >10 >10 29.6 ± 3.62 >10 10.4 ± 3.36
5-MeOAMT >10 >10 21.2 ± 12.3 >1 >10
R-DOI >10 >10 >10 2.11 10.1 ± 0.60
Apraclonidine 0.033 ± 0.005 0.195 ± 0.069
Brimonidine


0.027 ± 0.005

0.434 ± 0.088
  • a Radioligand [3H]7-MeO-prazosin, rat cerebral cortex.

  • b [3H]7-MeO-prazosin, rat liver.

  • c [3H]Clonidine, cloned human receptor.

  • d [3H]MK-912 [(2S, 12bS)1′,3′-dimethylspiro (1,3,4,5′6,6′,7,12b-octahydro-2H-benzo [b]furo[2,3-a]quinolizine)-2,4′-pyrimidin-2′-one], NG108 neuroblastoma cells.